Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.

Saved in:
Bibliographic Details
Title: Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.
Authors: Tang, Z.1, Du, R.1, Jiang, S.1, Wu, C.2,3,4, Barkauskas, D. S.2,3,4, Richey, J.2,3,4, Molter, J.2,3,4, Lam, M.4, Flask, C.2,3,4, Gerson, S.1,4, Dowlati, A.1,4, Liu, L.1,4, Lee, Z.2,3,4, Halmos, B.1,4, Wang, Y.2,3,4, Kern, J. A.4,5, Ma, P. C.1,4 patrick.ma@case.edu
Source: British Journal of Cancer. 9/16/2008, Vol. 99 Issue 6, p911-922. 12p. 1 Color Photograph, 2 Black and White Photographs, 3 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6604559